speb/financial-data huggingface dataset:
CLMT balance_sheet (quarterly, 2025-12-31) — Restricted Cash: 80000000.00
CLMT balance_sheet (annual, 2025-12-31) — Retained Earnings: -1573400000.00
CLMT balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -1573400000.00
CLMT cash_flow (annual, 2025-12-31) — Sale Of Business: 96900000.00
CLMT cash_flow (quarterly, 2025-12-31) — Sale Of Business: 1500000.00
CLMT income_statement (annual, 2025-12-31) — Selling And Marketing Expense: 47900000.00
CLMT income_statement (quarterly, 2025-12-31) — Selling And Marketing Expense: 12500000.00
CLMT income_statement (annual, 2025-12-31) — Selling General And Administration: 171700000.00
CLMT income_statement (quarterly, 2025-12-31) — Selling General And Administration: 51700000.00
CLMT balance_sheet (annual, 2025-12-31) — Share Issued: 86776552.00
CLMT balance_sheet (quarterly, 2025-12-31) — Share Issued: 86776552.00
CLMT income_statement (annual, 2025-12-31) — Special Income Charges: 7100000.00
CLMT income_statement (quarterly, 2025-12-31) — Special Income Charges: -1500000.00
CLMT cash_flow (annual, 2025-12-31) — Stock Based Compensation: -4500000.00
CLMT balance_sheet (annual, 2025-12-31) — Stockholders Equity: -732700000.00
CLMT balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: -732700000.00
CLMT balance_sheet (annual, 2025-12-31) — Tangible Book Value: -881900000.00
CLMT balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: -881900000.00
CLMT income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 3318000.00
CLMT income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 2436000.00
CLMT income_statement (annual, 2025-12-31) — Tax Provision: -92600000.00
CLMT income_statement (quarterly, 2025-12-31) — Tax Provision: -51800000.00
CLMT income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.21
CLMT income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.21
CLMT balance_sheet (annual, 2025-12-31) — Total Assets: 2688900000.00
CLMT balance_sheet (quarterly, 2025-12-31) — Total Assets: 2688900000.00
CLMT balance_sheet (annual, 2025-12-31) — Total Capitalization: 1344600000.00
CLMT balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 1344600000.00
CLMT balance_sheet (annual, 2025-12-31) — Total Debt: 2459100000.00
CLMT balance_sheet (quarterly, 2025-12-31) — Total Debt: 2459100000.00
CLMT balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: -487100000.00
CLMT balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: -487100000.00
CLMT income_statement (annual, 2025-12-31) — Total Expenses: 4082900000.00
CLMT income_statement (quarterly, 2025-12-31) — Total Expenses: 1101800000.00
CLMT balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 3176000000.00
CLMT balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 3176000000.00
CLMT balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 1831100000.00
CLMT balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 1831100000.00
CLMT balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 2335300000.00
CLMT balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 2335300000.00
CLMT income_statement (annual, 2025-12-31) — Total Operating Income As Reported: 108700000.00
CLMT income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: -64500000.00
CLMT balance_sheet (annual, 2025-12-31) — Total Tax Payable: 17700000.00
CLMT balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 17700000.00
CLMT income_statement (annual, 2025-12-31) — Total Unusual Items: 15800000.00
CLMT income_statement (quarterly, 2025-12-31) — Total Unusual Items: 11600000.00
CLMT income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: 15800000.00
CLMT income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: 11600000.00
CLMT balance_sheet (annual, 2025-12-31) — Work In Process: 101400000.00
CLMT balance_sheet (quarterly, 2025-12-31) — Work In Process: 101400000.00
CLMT balance_sheet (annual, 2025-12-31) — Working Capital: 17100000.00
CLMT balance_sheet (quarterly, 2025-12-31) — Working Capital: 17100000.00
CLMT income_statement (annual, 2025-12-31) — Write Off: 1300000.00
CLMT income_statement (quarterly, 2026-03-31) — +Operating Expense: 83800000.00
CLMT income_statement (quarterly, 2026-03-31) — +Total Revenue: 1029700000.00
CLMT balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 353300000.00
CLMT balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 358400000.00
CLMT balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 845300000.00
CLMT balance_sheet (quarterly, 2026-03-31) — Allowance For Doubtful Accounts Receivable: -1600000.00
CLMT income_statement (quarterly, 2026-03-31) — Basic Average Shares: 86995431.00
CLMT income_statement (quarterly, 2026-03-31) — Basic EPS: -3.64
CLMT cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 205100000.00
CLMT cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -13200000.00
CLMT balance_sheet (quarterly, 2026-03-31) — Capital Stock: 900000.00
CLMT balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 138600000.00
CLMT balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 138600000.00
CLMT cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: 73400000.00
CLMT cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -13200000.00
CLMT cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: -86200000.00
CLMT cash_flow (quarterly, 2026-03-31) — Cash From Discontinued Investing Activities: -500000.00
CLMT cash_flow (quarterly, 2026-03-31) — Change In Account Payable: 57000000.00
CLMT cash_flow (quarterly, 2026-03-31) — Change In Accrued Expense: -40500000.00
CLMT cash_flow (quarterly, 2026-03-31) — Change In Income Tax Payable: -6900000.00
CLMT cash_flow (quarterly, 2026-03-31) — Change In Interest Payable: -21000000.00
CLMT cash_flow (quarterly, 2026-03-31) — Change In Inventory: 41900000.00
CLMT cash_flow (quarterly, 2026-03-31) — Change In Other Current Assets: -22900000.00
CLMT cash_flow (quarterly, 2026-03-31) — Change In Other Current Liabilities: 6100000.00
CLMT cash_flow (quarterly, 2026-03-31) — Change In Payable: 50100000.00
CLMT cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: 9600000.00
CLMT cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: 7100000.00
CLMT cash_flow (quarterly, 2026-03-31) — Change In Receivables: -126400000.00
CLMT cash_flow (quarterly, 2026-03-31) — Change In Tax Payable: -6900000.00
CLMT cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -84600000.00
CLMT cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: -126400000.00
CLMT cash_flow (quarterly, 2026-03-31) — Changes In Cash: -26500000.00
CLMT balance_sheet (quarterly, 2026-03-31) — Common Stock: 900000.00
CLMT balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: -1043200000.00
CLMT income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 1117200000.00
CLMT balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 118500000.00
CLMT balance_sheet (quarterly, 2026-03-31) — Current Assets: 927900000.00
CLMT balance_sheet (quarterly, 2026-03-31) — Current Debt: 32600000.00
CLMT balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 32600000.00
CLMT balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 963100000.00
CLMT cash_flow (quarterly, 2026-03-31) — Depreciation: 33000000.00
CLMT cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 33000000.00
CLMT cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 33000000.00
CLMT income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 86995431.00
CLMT income_statement (quarterly, 2026-03-31) — Diluted EPS: -3.64
CLMT income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -317000000.00
CLMT income_statement (quarterly, 2026-03-31) — EBIT: -286700000.00
CLMT income_statement (quarterly, 2026-03-31) — EBITDA: -253700000.00
CLMT cash_flow (quarterly, 2026-03-31) — End Cash Position: 178600000.00
CLMT cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: 73400000.00
CLMT balance_sheet (quarterly, 2026-03-31) — Finished Goods: 199200000.00
CLMT cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -99400000.00
CLMT cash_flow (quarterly, 2026-03-31) — Gain Loss On Investment Securities: 102700000.00
CLMT cash_flow (quarterly, 2026-03-31) — Gain Loss On Sale Of Business: 0.00
CLMT income_statement (quarterly, 2026-03-31) — Gain On Sale Of Business: 0.00
CLMT income_statement (quarterly, 2026-03-31) — Gain On Sale Of Security: -115400000.00
CLMT balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -6800000.00
CLMT income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 66000000.00
CLMT balance_sheet (quarterly, 2026-03-31) — Gross Accounts Receivable: 360000000.00
CLMT income_statement (quarterly, 2026-03-31) — Gross Profit: -87500000.00
CLMT balance_sheet (quarterly, 2026-03-31) — Hedging Assets Current: 0.00
CLMT income_statement (quarterly, 2026-03-31) — Interest Expense: 51100000.00
CLMT income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 51100000.00
CLMT cash_flow (quarterly, 2026-03-31) — Interest Paid Supplemental Data: 57300000.00
CLMT balance_sheet (quarterly, 2026-03-31) — Interest Payable: 27800000.00
CLMT balance_sheet (quarterly, 2026-03-31) — Inventory: 369500000.00
CLMT balance_sheet (quarterly, 2026-03-31) — Invested Capital: 1288800000.00
CLMT cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -13700000.00
CLMT cash_flow (quarterly, 2026-03-31) — Issuance Of Debt: 1096000000.00
CLMT balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 2299400000.00
CLMT balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 2299400000.00
CLMT cash_flow (quarterly, 2026-03-31) — Long Term Debt Issuance: 1096000000.00
CLMT cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -987000000.00
CLMT balance_sheet (quarterly, 2026-03-31) — Minority Interest: 250600000.00
CLMT cash_flow (quarterly, 2026-03-31) — Net Business Purchase And Sale: 0.00
CLMT balance_sheet (quarterly, 2026-03-31) — Net Debt: 2193400000.00
CLMT income_statement (quarterly, 2026-03-31) — Net Income: -317000000.00
CLMT income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -317000000.00
CLMT income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -317000000.00
CLMT income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -317000000.00
CLMT income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -317000000.00
CLMT cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: -317000000.00
CLMT income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -317000000.00
CLMT income_statement (quarterly, 2026-03-31) — Net Interest Income: -51100000.00
CLMT cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: 109000000.00
CLMT cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: 109000000.00
CLMT income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -51100000.00
CLMT cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: -35600000.00
CLMT balance_sheet (quarterly, 2026-03-31) — Net PPE: 1336400000.00
CLMT cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -13200000.00
CLMT balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: -1043200000.00
CLMT income_statement (quarterly, 2026-03-31) — Normalized EBITDA: -136600000.00
CLMT income_statement (quarterly, 2026-03-31) — Normalized Income: -207160200.00
CLMT cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: -86200000.00
CLMT cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: 104400000.00
CLMT income_statement (quarterly, 2026-03-31) — Operating Income: -171300000.00
CLMT income_statement (quarterly, 2026-03-31) — Operating Revenue: 1029700000.00
CLMT balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 87040558.00
CLMT balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 21400000.00
CLMT balance_sheet (quarterly, 2026-03-31) — Other Current Borrowings: 32600000.00
CLMT balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 458700000.00
CLMT balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: -6800000.00
CLMT balance_sheet (quarterly, 2026-03-31) — Other Equity Interest: 7800000.00
CLMT income_statement (quarterly, 2026-03-31) — Other Gand A: 66000000.00
CLMT income_statement (quarterly, 2026-03-31) — Other Income Expense: -115400000.00
CLMT cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 140600000.00
CLMT balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 490700000.00
CLMT balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 285100000.00
CLMT income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 1700000.00
CLMT income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 5500000.00
CLMT income_statement (quarterly, 2026-03-31) — Other Special Charges: 1700000.00
CLMT balance_sheet (quarterly, 2026-03-31) — Payables: 353300000.00
CLMT balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 471800000.00
CLMT income_statement (quarterly, 2026-03-31) — Pretax Income: -337800000.00
CLMT cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -13200000.00
CLMT balance_sheet (quarterly, 2026-03-31) — Raw Materials: 81300000.00
CLMT balance_sheet (quarterly, 2026-03-31) — Receivables: 358400000.00
CLMT income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 1117200000.00
CLMT income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 33000000.00
CLMT cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -987000000.00
CLMT balance_sheet (quarterly, 2026-03-31) — Restricted Cash: 40000000.00
CLMT balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -1890400000.00
CLMT cash_flow (quarterly, 2026-03-31) — Sale Of Business: 0.00
CLMT income_statement (quarterly, 2026-03-31) — Selling And Marketing Expense: 12300000.00
CLMT income_statement (quarterly, 2026-03-31) — Selling General And Administration: 78300000.00
CLMT balance_sheet (quarterly, 2026-03-31) — Share Issued: 87040558.00
CLMT income_statement (quarterly, 2026-03-31) — Special Income Charges: -1700000.00
CLMT cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 37400000.00
CLMT balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: -1043200000.00
CLMT balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: -1043200000.00
CLMT income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: -7260200.00
CLMT income_statement (quarterly, 2026-03-31) — Tax Provision: -20800000.00
CLMT income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.06
CLMT balance_sheet (quarterly, 2026-03-31) — Total Assets: 2755000000.00
CLMT balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 1256200000.00
CLMT balance_sheet (quarterly, 2026-03-31) — Total Debt: 2332000000.00
CLMT balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: -792600000.00
CLMT income_statement (quarterly, 2026-03-31) — Total Expenses: 1201000000.00
CLMT balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 3547600000.00
CLMT balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 1827100000.00
CLMT balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 2584500000.00
CLMT income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: -171300000.00
CLMT income_statement (quarterly, 2026-03-31) — Total Unusual Items: -117100000.00
CLMT income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: -117100000.00
CLMT balance_sheet (quarterly, 2026-03-31) — Work In Process: 89000000.00
CLMT balance_sheet (quarterly, 2026-03-31) — Working Capital: -35200000.00
CLN.SW income_statement (annual, 2021-12-31) — Basic Average Shares: 329336789.00
CLN.SW income_statement (annual, 2021-12-31) — Basic EPS: 1.04
CLN.SW income_statement (annual, 2021-12-31) — Diluted Average Shares: 331390284.00
CLN.SW balance_sheet (annual, 2021-12-31) — Inventories Adjustments Allowances: -234000000.00
CLN.SW income_statement (annual, 2021-12-31) — Net Income Discontinuous Operations: 81000000.00
CLN.SW cash_flow (annual, 2021-12-31) — Net Other Financing Charges: 19000000.00
CLN.SW balance_sheet (annual, 2021-12-31) — Non Current Prepaid Assets: 76000000.00
CLN.SW balance_sheet (annual, 2021-12-31) — Other Current Assets: -48000000.00
CLN.SW balance_sheet (annual, 2021-12-31) — Other Current Liabilities: -5000000.00
CLN.SW balance_sheet (annual, 2021-12-31) — Other Payable: 55000000.00
CLN.SW balance_sheet (annual, 2021-12-31) — Other Properties: -12000000.00
CLN.SW cash_flow (annual, 2021-12-31) — Sale Of Business: 2000000.00
CLN.SW cash_flow (annual, 2021-12-31) — Sale Of Investment: 254000000.00
CLN.SW income_statement (annual, 2022-12-31) — +Operating Expense: 994000000.00
CLN.SW income_statement (annual, 2022-12-31) — +Total Revenue: 5198000000.00
CLN.SW balance_sheet (annual, 2022-12-31) — Accounts Payable: 1009000000.00
CLN.SW balance_sheet (annual, 2022-12-31) — Accounts Receivable: 725000000.00
CLN.SW balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -2389000000.00
CLN.SW balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 259000000.00
CLN.SW balance_sheet (annual, 2022-12-31) — Allowance For Doubtful Accounts Receivable: -10000000.00
CLN.SW cash_flow (annual, 2022-12-31) — Amortization Cash Flow: 38000000.00
CLN.SW balance_sheet (annual, 2022-12-31) — Assets Held For Sale Current: 50000000.00
CLN.SW income_statement (annual, 2022-12-31) — Basic Average Shares: 329164586.00
CLN.SW income_statement (annual, 2022-12-31) — Basic EPS: 0.26
CLN.SW cash_flow (annual, 2022-12-31) — Beginning Cash Position: 415000000.00
CLN.SW balance_sheet (annual, 2022-12-31) — Buildings And Improvements: 1119000000.00
CLN.SW cash_flow (annual, 2022-12-31) — Capital Expenditure: -212000000.00
CLN.SW balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 239000000.00
CLN.SW balance_sheet (annual, 2022-12-31) — Capital Stock: 863000000.00
CLN.SW balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 394000000.00
CLN.SW balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 758000000.00
CLN.SW cash_flow (annual, 2022-12-31) — Cash Dividends Paid: -132000000.00
CLN.SW balance_sheet (annual, 2022-12-31) — Cash Equivalents: 30000000.00
CLN.SW balance_sheet (annual, 2022-12-31) — Cash Financial: 364000000.00
CLN.SW cash_flow (annual, 2022-12-31) — Change In Inventory: -179000000.00
CLN.SW cash_flow (annual, 2022-12-31) — Change In Other Current Assets: -49000000.00
CLN.SW cash_flow (annual, 2022-12-31) — Change In Payable: 77000000.00
CLN.SW cash_flow (annual, 2022-12-31) — Change In Receivables: -40000000.00
CLN.SW cash_flow (annual, 2022-12-31) — Change In Working Capital: -143000000.00
CLN.SW cash_flow (annual, 2022-12-31) — Changes In Cash: -10000000.00
CLN.SW balance_sheet (annual, 2022-12-31) — Common Stock: 863000000.00
CLN.SW balance_sheet (annual, 2022-12-31) — Common Stock Equity: 2341000000.00
CLN.SW cash_flow (annual, 2022-12-31) — Common Stock Payments: -8000000.00
CLN.SW balance_sheet (annual, 2022-12-31) — Construction In Progress: 178000000.00
CLN.SW income_statement (annual, 2022-12-31) — Cost Of Revenue: 4173000000.00
CLN.SW balance_sheet (annual, 2022-12-31) — Current Assets: 2669000000.00
CLN.SW balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 44000000.00
CLN.SW balance_sheet (annual, 2022-12-31) — Current Debt: 355000000.00
CLN.SW balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 399000000.00
CLN.SW balance_sheet (annual, 2022-12-31) — Current Liabilities: 1862000000.00
CLN.SW balance_sheet (annual, 2022-12-31) — Current Provisions: 215000000.00
CLN.SW cash_flow (annual, 2022-12-31) — Deferred Tax: 102000000.00
CLN.SW balance_sheet (annual, 2022-12-31) — Defined Pension Benefit: 61000000.00
CLN.SW cash_flow (annual, 2022-12-31) — Depreciation: 238000000.00
CLN.SW cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 276000000.00
CLN.SW income_statement (annual, 2022-12-31) — Diluted Average Shares: 330771006.00
CLN.SW income_statement (annual, 2022-12-31) — Diluted EPS: 0.26
CLN.SW income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 84000000.00
CLN.SW cash_flow (annual, 2022-12-31) — Dividend Received Cfo: 40000000.00
CLN.SW income_statement (annual, 2022-12-31) — EBIT: 90000000.00
CLN.SW income_statement (annual, 2022-12-31) — EBITDA: 366000000.00
CLN.SW cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: -11000000.00
CLN.SW cash_flow (annual, 2022-12-31) — End Cash Position: 394000000.00
CLN.SW cash_flow (annual, 2022-12-31) — Financing Cash Flow: -666000000.00
CLN.SW balance_sheet (annual, 2022-12-31) — Finished Goods: 452000000.00
CLN.SW cash_flow (annual, 2022-12-31) — Free Cash Flow: 290000000.00
CLN.SW cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of Business: -22000000.00
CLN.SW income_statement (annual, 2022-12-31) — General And Administrative Expense: 834000000.00
CLN.SW balance_sheet (annual, 2022-12-31) — Goodwill: 870000000.00
CLN.SW balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 997000000.00
CLN.SW balance_sheet (annual, 2022-12-31) — Gross Accounts Receivable: 735000000.00
CLN.SW balance_sheet (annual, 2022-12-31) — Gross PPE: 4178000000.00
CLN.SW income_statement (annual, 2022-12-31) — Gross Profit: 1025000000.00
CLN.SW income_statement (annual, 2022-12-31) — Interest Expense: 84000000.00
CLN.SW income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 84000000.00
CLN.SW income_statement (annual, 2022-12-31) — Interest Income: 9000000.00
CLN.SW income_statement (annual, 2022-12-31) — Interest Income Non Operating: 9000000.00
CLN.SW cash_flow (annual, 2022-12-31) — Interest Paid Cff: -54000000.00
CLN.SW cash_flow (annual, 2022-12-31) — Interest Received Cfi: 14000000.00
CLN.SW balance_sheet (annual, 2022-12-31) — Inventories Adjustments Allowances: -19000000.00
CLN.SW balance_sheet (annual, 2022-12-31) — Inventory: 796000000.00
CLN.SW balance_sheet (annual, 2022-12-31) — Invested Capital: 3566000000.00
CLN.SW cash_flow (annual, 2022-12-31) — Investing Cash Flow: 154000000.00
CLN.SW balance_sheet (annual, 2022-12-31) — Investments In Other Ventures Under Equity Method: 186000000.00
CLN.SW balance_sheet (annual, 2022-12-31) — Investmentsin Associatesat Cost: 327000000.00
CLN.SW cash_flow (annual, 2022-12-31) — Issuance Of Debt: 204000000.00
CLN.SW balance_sheet (annual, 2022-12-31) — Land And Improvements: 297000000.00
CLN.SW balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 195000000.00
CLN.SW balance_sheet (annual, 2022-12-31) — Long Term Debt: 870000000.00
CLN.SW balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 1065000000.00
CLN.SW cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 204000000.00
CLN.SW cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -602000000.00
CLN.SW balance_sheet (annual, 2022-12-31) — Long Term Equity Investment: 513000000.00
CLN.SW balance_sheet (annual, 2022-12-31) — Long Term Provisions: 178000000.00
CLN.SW balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 2590000000.00
CLN.SW balance_sheet (annual, 2022-12-31) — Minority Interest: 172000000.00
CLN.SW income_statement (annual, 2022-12-31) — Minority Interests: -32000000.00
CLN.SW cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: 67000000.00
CLN.SW cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: -8000000.00
CLN.SW balance_sheet (annual, 2022-12-31) — Net Debt: 831000000.00
CLN.SW income_statement (annual, 2022-12-31) — Net Income: 84000000.00
CLN.SW income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 84000000.00
CLN.SW income_statement (annual, 2022-12-31) — Net Income Continuous Operations: -101000000.00
CLN.SW income_statement (annual, 2022-12-31) — Net Income Discontinuous Operations: 217000000.00
CLN.SW income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 84000000.00
CLN.SW income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: -133000000.00
CLN.SW cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 116000000.00
CLN.SW income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 116000000.00
CLN.SW cash_flow (annual, 2022-12-31) — Net Intangibles Purchase And Sale: -3000000.00
CLN.SW income_statement (annual, 2022-12-31) — Net Interest Income: -66000000.00
CLN.SW cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: -303000000.00
CLN.SW cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: -398000000.00
CLN.SW cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: -398000000.00
CLN.SW income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -66000000.00
CLN.SW cash_flow (annual, 2022-12-31) — Net Other Financing Charges: 14000000.00
CLN.SW cash_flow (annual, 2022-12-31) — Net Other Investing Changes: 579000000.00
CLN.SW balance_sheet (annual, 2022-12-31) — Net PPE: 1789000000.00
CLN.SW cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -200000000.00
CLN.SW balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 1344000000.00
CLN.SW balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Assets: 120000000.00
CLN.SW balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Liabilities: 27000000.00
CLN.SW balance_sheet (annual, 2022-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 488000000.00
CLN.SW balance_sheet (annual, 2022-12-31) — Non Current Prepaid Assets: 61000000.00
CLN.SW income_statement (annual, 2022-12-31) — Normalized EBITDA: 366000000.00
CLN.SW income_statement (annual, 2022-12-31) — Normalized Income: -133000000.00
CLN.SW cash_flow (annual, 2022-12-31) — Operating Cash Flow: 502000000.00
CLN.SW income_statement (annual, 2022-12-31) — Operating Income: 31000000.00
CLN.SW income_statement (annual, 2022-12-31) — Operating Revenue: 5198000000.00
CLN.SW balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 329016801.00
CLN.SW balance_sheet (annual, 2022-12-31) — Other Current Liabilities: 108000000.00
CLN.SW balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 127000000.00
CLN.SW cash_flow (annual, 2022-12-31) — Other Non Cash Items: 56000000.00
CLN.SW balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: 55000000.00
CLN.SW balance_sheet (annual, 2022-12-31) — Other Payable: 39000000.00
CLN.SW balance_sheet (annual, 2022-12-31) — Other Properties: -6000000.00
CLN.SW balance_sheet (annual, 2022-12-31) — Other Receivables: 286000000.00
CLN.SW balance_sheet (annual, 2022-12-31) — Other Short Term Investments: 364000000.00
CLN.SW income_statement (annual, 2022-12-31) — Other Special Charges: 16000000.00
CLN.SW income_statement (annual, 2022-12-31) — Otherunder Preferred Stock Dividend: 0.00
CLN.SW balance_sheet (annual, 2022-12-31) — Payables: 1242000000.00
CLN.SW income_statement (annual, 2022-12-31) — Pretax Income: 6000000.00
CLN.SW balance_sheet (annual, 2022-12-31) — Properties: 0.00
CLN.SW cash_flow (annual, 2022-12-31) — Purchase Of Business: -64000000.00
CLN.SW cash_flow (annual, 2022-12-31) — Purchase Of Intangibles: -3000000.00
CLN.SW cash_flow (annual, 2022-12-31) — Purchase Of Investment: -303000000.00
CLN.SW cash_flow (annual, 2022-12-31) — Purchase Of PPE: -209000000.00
CLN.SW balance_sheet (annual, 2022-12-31) — Raw Materials: 363000000.00
CLN.SW income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 4173000000.00
CLN.SW income_statement (annual, 2022-12-31) — Reconciled Depreciation: 276000000.00
CLN.SW cash_flow (annual, 2022-12-31) — Repayment Of Debt: -602000000.00
CLN.SW cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: -8000000.00
CLN.SW income_statement (annual, 2022-12-31) — Research And Development: 160000000.00
CLN.SW balance_sheet (annual, 2022-12-31) — Retained Earnings: 2651000000.00
CLN.SW cash_flow (annual, 2022-12-31) — Sale Of Business: 131000000.00
CLN.SW cash_flow (annual, 2022-12-31) — Sale Of PPE: 9000000.00
CLN.SW income_statement (annual, 2022-12-31) — Selling General And Administration: 834000000.00
CLN.SW balance_sheet (annual, 2022-12-31) — Share Issued: 331939199.00
CLN.SW income_statement (annual, 2022-12-31) — Special Income Charges: -16000000.00
CLN.SW balance_sheet (annual, 2022-12-31) — Stockholders Equity: 2341000000.00
CLN.SW balance_sheet (annual, 2022-12-31) — Tangible Book Value: 1344000000.00
CLN.SW income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 0.00
CLN.SW income_statement (annual, 2022-12-31) — Tax Provision: 107000000.00
CLN.SW income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.09
CLN.SW balance_sheet (annual, 2022-12-31) — Taxes Receivable: 54000000.00
CLN.SW cash_flow (annual, 2022-12-31) — Taxes Refund Paid: -120000000.00
CLN.SW balance_sheet (annual, 2022-12-31) — Total Assets: 6188000000.00
CLN.SW balance_sheet (annual, 2022-12-31) — Total Capitalization: 3211000000.00
CLN.SW balance_sheet (annual, 2022-12-31) — Total Debt: 1464000000.00
CLN.SW balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 2513000000.00
CLN.SW income_statement (annual, 2022-12-31) — Total Expenses: 5167000000.00
CLN.SW balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 3675000000.00
CLN.SW balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 3519000000.00
CLN.SW balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 1813000000.00
CLN.SW income_statement (annual, 2022-12-31) — Total Operating Income As Reported: 72000000.00
CLN.SW income_statement (annual, 2022-12-31) — Total Other Finance Cost: -9000000.00
CLN.SW balance_sheet (annual, 2022-12-31) — Total Tax Payable: 233000000.00
CLN.SW income_statement (annual, 2022-12-31) — Total Unusual Items: -16000000.00
CLN.SW income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: -16000000.00
CLN.SW balance_sheet (annual, 2022-12-31) — Treasury Shares Number: 2922398.00
CLN.SW balance_sheet (annual, 2022-12-31) — Treasury Stock: 8000000.00
CLN.SW balance_sheet (annual, 2022-12-31) — Working Capital: 807000000.00
CLN.SW income_statement (annual, 2023-12-31) — +Operating Expense: 869000000.00
CLN.SW income_statement (annual, 2023-12-31) — +Total Revenue: 4377000000.00
CLN.SW balance_sheet (annual, 2023-12-31) — Accounts Payable: 740000000.00
CLN.SW balance_sheet (annual, 2023-12-31) — Accounts Receivable: 567000000.00
CLN.SW balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -2344000000.00
CLN.SW balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 259000000.00
CLN.SW balance_sheet (annual, 2023-12-31) — Allowance For Doubtful Accounts Receivable: -10000000.00
CLN.SW cash_flow (annual, 2023-12-31) — Amortization Cash Flow: 20000000.00
CLN.SW balance_sheet (annual, 2023-12-31) — Assets Held For Sale Current: 1000000.00
CLN.SW income_statement (annual, 2023-12-31) — Basic Average Shares: 328960260.00
CLN.SW income_statement (annual, 2023-12-31) — Basic EPS: 0.41
CLN.SW cash_flow (annual, 2023-12-31) — Beginning Cash Position: 394000000.00
CLN.SW balance_sheet (annual, 2023-12-31) — Buildings And Improvements: 1047000000.00
CLN.SW cash_flow (annual, 2023-12-31) — Capital Expenditure: -207000000.00
CLN.SW balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 251000000.00
CLN.SW balance_sheet (annual, 2023-12-31) — Capital Stock: 724000000.00
CLN.SW balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 488000000.00
CLN.SW balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 691000000.00
CLN.SW cash_flow (annual, 2023-12-31) — Cash Dividends Paid: -138000000.00
CLN.SW balance_sheet (annual, 2023-12-31) — Cash Equivalents: 159000000.00
CLN.SW balance_sheet (annual, 2023-12-31) — Cash Financial: 329000000.00
CLN.SW cash_flow (annual, 2023-12-31) — Change In Inventory: 66000000.00
CLN.SW cash_flow (annual, 2023-12-31) — Change In Other Current Assets: -35000000.00
CLN.SW cash_flow (annual, 2023-12-31) — Change In Payable: -200000000.00
CLN.SW cash_flow (annual, 2023-12-31) — Change In Receivables: 94000000.00
CLN.SW cash_flow (annual, 2023-12-31) — Change In Working Capital: -2000000.00
CLN.SW cash_flow (annual, 2023-12-31) — Changes In Cash: 113000000.00
CLN.SW balance_sheet (annual, 2023-12-31) — Common Stock: 724000000.00
CLN.SW balance_sheet (annual, 2023-12-31) — Common Stock Equity: 2018000000.00
CLN.SW cash_flow (annual, 2023-12-31) — Common Stock Payments: -8000000.00
CLN.SW balance_sheet (annual, 2023-12-31) — Construction In Progress: 206000000.00
CLN.SW income_statement (annual, 2023-12-31) — Cost Of Revenue: 3268000000.00
CLN.SW balance_sheet (annual, 2023-12-31) — Current Assets: 2218000000.00
CLN.SW balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 115000000.00
CLN.SW balance_sheet (annual, 2023-12-31) — Current Debt: 333000000.00
CLN.SW balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 448000000.00
CLN.SW balance_sheet (annual, 2023-12-31) — Current Liabilities: 1589000000.00
CLN.SW balance_sheet (annual, 2023-12-31) — Current Provisions: 241000000.00
CLN.SW cash_flow (annual, 2023-12-31) — Deferred Tax: 3000000.00
CLN.SW balance_sheet (annual, 2023-12-31) — Defined Pension Benefit: 44000000.00
CLN.SW cash_flow (annual, 2023-12-31) — Depreciation: 216000000.00
CLN.SW cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 236000000.00
CLN.SW income_statement (annual, 2023-12-31) — Diluted Average Shares: 330595491.00
CLN.SW income_statement (annual, 2023-12-31) — Diluted EPS: 0.41
CLN.SW income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: 134000000.00
CLN.SW cash_flow (annual, 2023-12-31) — Dividend Received Cfo: 44000000.00
CLN.SW income_statement (annual, 2023-12-31) — EBIT: 326000000.00
CLN.SW income_statement (annual, 2023-12-31) — EBITDA: 562000000.00
CLN.SW cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: -19000000.00
CLN.SW cash_flow (annual, 2023-12-31) — End Cash Position: 488000000.00
CLN.SW cash_flow (annual, 2023-12-31) — Financing Cash Flow: -394000000.00
CLN.SW balance_sheet (annual, 2023-12-31) — Finished Goods: 342000000.00
CLN.SW cash_flow (annual, 2023-12-31) — Free Cash Flow: 214000000.00
CLN.SW cash_flow (annual, 2023-12-31) — Gain Loss On Investment Securities: 11000000.00
CLN.SW cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of Business: -60000000.00
CLN.SW income_statement (annual, 2023-12-31) — General And Administrative Expense: 709000000.00
CLN.SW balance_sheet (annual, 2023-12-31) — Goodwill: 814000000.00
CLN.SW balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 911000000.00
CLN.SW balance_sheet (annual, 2023-12-31) — Gross Accounts Receivable: 577000000.00
CLN.SW balance_sheet (annual, 2023-12-31) — Gross PPE: 3954000000.00
CLN.SW income_statement (annual, 2023-12-31) — Gross Profit: 1109000000.00
CLN.SW income_statement (annual, 2023-12-31) — Interest Expense: 108000000.00
CLN.SW income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 108000000.00
CLN.SW income_statement (annual, 2023-12-31) — Interest Income: 18000000.00
CLN.SW income_statement (annual, 2023-12-31) — Interest Income Non Operating: 18000000.00
CLN.SW cash_flow (annual, 2023-12-31) — Interest Paid Cff: -47000000.00
CLN.SW cash_flow (annual, 2023-12-31) — Interest Received Cfi: 41000000.00
CLN.SW balance_sheet (annual, 2023-12-31) — Inventories Adjustments Allowances: 0.00
CLN.SW balance_sheet (annual, 2023-12-31) — Inventory: 624000000.00
CLN.SW balance_sheet (annual, 2023-12-31) — Invested Capital: 3116000000.00
CLN.SW cash_flow (annual, 2023-12-31) — Investing Cash Flow: 86000000.00
CLN.SW balance_sheet (annual, 2023-12-31) — Investments In Other Ventures Under Equity Method: 199000000.00
CLN.SW balance_sheet (annual, 2023-12-31) — Investmentsin Associatesat Cost: 236000000.00
CLN.SW cash_flow (annual, 2023-12-31) — Issuance Of Debt: 196000000.00
CLN.SW balance_sheet (annual, 2023-12-31) — Land And Improvements: 278000000.00
CLN.SW balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 136000000.00
CLN.SW balance_sheet (annual, 2023-12-31) — Long Term Debt: 765000000.00
CLN.SW balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 901000000.00
CLN.SW cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 196000000.00
CLN.SW cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -308000000.00
CLN.SW balance_sheet (annual, 2023-12-31) — Long Term Equity Investment: 435000000.00
CLN.SW balance_sheet (annual, 2023-12-31) — Long Term Provisions: 153000000.00
CLN.SW balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 2423000000.00
CLN.SW balance_sheet (annual, 2023-12-31) — Minority Interest: 162000000.00
CLN.SW income_statement (annual, 2023-12-31) — Minority Interests: -45000000.00
CLN.SW cash_flow (annual, 2023-12-31) — Net Business Purchase And Sale: 117000000.00
CLN.SW cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: -8000000.00
CLN.SW balance_sheet (annual, 2023-12-31) — Net Debt: 610000000.00
CLN.SW income_statement (annual, 2023-12-31) — Net Income: 134000000.00
CLN.SW income_statement (annual, 2023-12-31) — Net Income Common Stockholders: 134000000.00
CLN.SW income_statement (annual, 2023-12-31) — Net Income Continuous Operations: 213000000.00
CLN.SW income_statement (annual, 2023-12-31) — Net Income Discontinuous Operations: -34000000.00
CLN.SW income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: 134000000.00
CLN.SW income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: 168000000.00
CLN.SW cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: 179000000.00
CLN.SW income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: 179000000.00
CLN.SW cash_flow (annual, 2023-12-31) — Net Intangibles Purchase And Sale: -2000000.00
CLN.SW income_statement (annual, 2023-12-31) — Net Interest Income: -64000000.00
CLN.SW cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: 128000000.00
CLN.SW cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: -112000000.00
CLN.SW cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: -112000000.00
CLN.SW income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -64000000.00
CLN.SW balance_sheet (annual, 2023-12-31) — Net PPE: 1610000000.00
CLN.SW cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -198000000.00
CLN.SW balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 1107000000.00
CLN.SW balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Assets: 129000000.00
CLN.SW balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Liabilities: 25000000.00
CLN.SW balance_sheet (annual, 2023-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 473000000.00
CLN.SW income_statement (annual, 2023-12-31) — Normalized EBITDA: 562000000.00
CLN.SW income_statement (annual, 2023-12-31) — Normalized Income: 168000000.00
CLN.SW cash_flow (annual, 2023-12-31) — Operating Cash Flow: 421000000.00
CLN.SW income_statement (annual, 2023-12-31) — Operating Income: 240000000.00
CLN.SW income_statement (annual, 2023-12-31) — Operating Revenue: 4377000000.00
CLN.SW balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 328848494.00
CLN.SW balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 97000000.00
CLN.SW cash_flow (annual, 2023-12-31) — Other Non Cash Items: 53000000.00
CLN.SW balance_sheet (annual, 2023-12-31) — Other Non Current Liabilities: 26000000.00
CLN.SW balance_sheet (annual, 2023-12-31) — Other Receivables: 257000000.00
CLN.SW balance_sheet (annual, 2023-12-31) — Other Short Term Investments: 203000000.00
CLN.SW income_statement (annual, 2023-12-31) — Other Special Charges: 13000000.00
CLN.SW income_statement (annual, 2023-12-31) — Otherunder Preferred Stock Dividend: 0.00
CLN.SW balance_sheet (annual, 2023-12-31) — Payables: 900000000.00
CLN.SW income_statement (annual, 2023-12-31) — Pretax Income: 218000000.00
CLN.SW balance_sheet (annual, 2023-12-31) — Properties: 0.00
CLN.SW cash_flow (annual, 2023-12-31) — Purchase Of Business: 0.00
CLN.SW cash_flow (annual, 2023-12-31) — Purchase Of Intangibles: -2000000.00
CLN.SW cash_flow (annual, 2023-12-31) — Purchase Of Investment: -27000000.00
CLN.SW cash_flow (annual, 2023-12-31) — Purchase Of PPE: -205000000.00
CLN.SW balance_sheet (annual, 2023-12-31) — Raw Materials: 282000000.00
CLN.SW income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 3268000000.00
CLN.SW income_statement (annual, 2023-12-31) — Reconciled Depreciation: 236000000.00
CLN.SW cash_flow (annual, 2023-12-31) — Repayment Of Debt: -308000000.00
CLN.SW cash_flow (annual, 2023-12-31) — Repurchase Of Capital Stock: -8000000.00
CLN.SW income_statement (annual, 2023-12-31) — Research And Development: 160000000.00
CLN.SW balance_sheet (annual, 2023-12-31) — Retained Earnings: 2686000000.00
CLN.SW cash_flow (annual, 2023-12-31) — Sale Of Business: 117000000.00
CLN.SW cash_flow (annual, 2023-12-31) — Sale Of Investment: 155000000.00
CLN.SW cash_flow (annual, 2023-12-31) — Sale Of PPE: 7000000.00
CLN.SW income_statement (annual, 2023-12-31) — Selling General And Administration: 709000000.00
CLN.SW balance_sheet (annual, 2023-12-31) — Share Issued: 331939199.00
CLN.SW income_statement (annual, 2023-12-31) — Special Income Charges: -13000000.00
CLN.SW balance_sheet (annual, 2023-12-31) — Stockholders Equity: 2018000000.00
CLN.SW balance_sheet (annual, 2023-12-31) — Tangible Book Value: 1107000000.00
CLN.SW income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
CLN.SW income_statement (annual, 2023-12-31) — Tax Provision: 5000000.00
CLN.SW income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.02
CLN.SW balance_sheet (annual, 2023-12-31) — Taxes Receivable: 78000000.00
CLN.SW cash_flow (annual, 2023-12-31) — Taxes Refund Paid: -111000000.00
CLN.SW balance_sheet (annual, 2023-12-31) — Total Assets: 5347000000.00
CLN.SW balance_sheet (annual, 2023-12-31) — Total Capitalization: 2783000000.00
CLN.SW balance_sheet (annual, 2023-12-31) — Total Debt: 1349000000.00
CLN.SW balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 2180000000.00
CLN.SW income_statement (annual, 2023-12-31) — Total Expenses: 4137000000.00
CLN.SW balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 3167000000.00
CLN.SW balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 3129000000.00
CLN.SW balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 1578000000.00
CLN.SW income_statement (annual, 2023-12-31) — Total Operating Income As Reported: 282000000.00
CLN.SW income_statement (annual, 2023-12-31) — Total Other Finance Cost: -26000000.00
CLN.SW balance_sheet (annual, 2023-12-31) — Total Tax Payable: 160000000.00
CLN.SW income_statement (annual, 2023-12-31) — Total Unusual Items: -13000000.00
CLN.SW income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: -13000000.00
CLN.SW balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 3090705.00
CLN.SW balance_sheet (annual, 2023-12-31) — Treasury Stock: 7000000.00
CLN.SW balance_sheet (annual, 2023-12-31) — Working Capital: 629000000.00
CLN.SW income_statement (annual, 2024-12-31) — +Operating Expense: 874000000.00
CLN.SW income_statement (annual, 2024-12-31) — +Total Revenue: 4152000000.00
CLN.SW balance_sheet (annual, 2024-12-31) — Accounts Payable: 746000000.00
CLN.SW balance_sheet (quarterly, 2024-12-31) — Accounts Payable: 746000000.00
CLN.SW balance_sheet (annual, 2024-12-31) — Accounts Receivable: 635000000.00
CLN.SW balance_sheet (quarterly, 2024-12-31) — Accounts Receivable: 635000000.00
CLN.SW balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -2445000000.00
CLN.SW balance_sheet (quarterly, 2024-12-31) — Accumulated Depreciation: -2445000000.00
CLN.SW balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 259000000.00
CLN.SW balance_sheet (quarterly, 2024-12-31) — Additional Paid In Capital: 259000000.00
CLN.SW balance_sheet (annual, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -16000000.00
CLN.SW balance_sheet (quarterly, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -16000000.00
CLN.SW cash_flow (annual, 2024-12-31) — Amortization Cash Flow: 36000000.00
CLN.SW balance_sheet (annual, 2024-12-31) — Assets Held For Sale Current: 12000000.00
CLN.SW balance_sheet (quarterly, 2024-12-31) — Assets Held For Sale Current: 12000000.00
CLN.SW cash_flow (annual, 2024-12-31) — Beginning Cash Position: 488000000.00
CLN.SW balance_sheet (annual, 2024-12-31) — Buildings And Improvements: 1157000000.00
CLN.SW balance_sheet (quarterly, 2024-12-31) — Buildings And Improvements: 1157000000.00
CLN.SW cash_flow (annual, 2024-12-31) — Capital Expenditure: -209000000.00
CLN.SW balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 192000000.00
CLN.SW balance_sheet (quarterly, 2024-12-31) — Capital Lease Obligations: 192000000.00
CLN.SW balance_sheet (annual, 2024-12-31) — Capital Stock: 584000000.00
CLN.SW balance_sheet (quarterly, 2024-12-31) — Capital Stock: 584000000.00
CLN.SW balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 388000000.00
CLN.SW balance_sheet (quarterly, 2024-12-31) — Cash And Cash Equivalents: 388000000.00
CLN.SW balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 471000000.00
CLN.SW balance_sheet (quarterly, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 471000000.00
CLN.SW cash_flow (annual, 2024-12-31) — Cash Dividends Paid: -139000000.00
CLN.SW balance_sheet (annual, 2024-12-31) — Cash Equivalents: 81000000.00
CLN.SW balance_sheet (quarterly, 2024-12-31) — Cash Equivalents: 81000000.00
CLN.SW balance_sheet (annual, 2024-12-31) — Cash Financial: 307000000.00
CLN.SW balance_sheet (quarterly, 2024-12-31) — Cash Financial: 307000000.00
CLN.SW cash_flow (annual, 2024-12-31) — Change In Inventory: -9000000.00
CLN.SW cash_flow (annual, 2024-12-31) — Change In Other Current Assets: -58000000.00
CLN.SW cash_flow (annual, 2024-12-31) — Change In Payable: 3000000.00
CLN.SW cash_flow (annual, 2024-12-31) — Change In Receivables: -47000000.00
CLN.SW cash_flow (annual, 2024-12-31) — Change In Working Capital: -128000000.00
CLN.SW cash_flow (annual, 2024-12-31) — Changes In Cash: -110000000.00
CLN.SW balance_sheet (annual, 2024-12-31) — Common Stock: 584000000.00
CLN.SW balance_sheet (quarterly, 2024-12-31) — Common Stock: 584000000.00
CLN.SW balance_sheet (annual, 2024-12-31) — Common Stock Equity: 2335000000.00
CLN.SW balance_sheet (quarterly, 2024-12-31) — Common Stock Equity: 2335000000.00
CLN.SW cash_flow (annual, 2024-12-31) — Common Stock Payments: -14000000.00
CLN.SW balance_sheet (annual, 2024-12-31) — Construction In Progress: 252000000.00
CLN.SW balance_sheet (quarterly, 2024-12-31) — Construction In Progress: 252000000.00
CLN.SW income_statement (annual, 2024-12-31) — Cost Of Revenue: 2893000000.00
CLN.SW balance_sheet (annual, 2024-12-31) — Current Assets: 2128000000.00
CLN.SW balance_sheet (quarterly, 2024-12-31) — Current Assets: 2128000000.00
CLN.SW balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 43000000.00
CLN.SW balance_sheet (quarterly, 2024-12-31) — Current Capital Lease Obligation: 43000000.00
CLN.SW balance_sheet (annual, 2024-12-31) — Current Debt: 270000000.00
CLN.SW balance_sheet (quarterly, 2024-12-31) — Current Debt: 270000000.00
CLN.SW balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 313000000.00
CLN.SW balance_sheet (quarterly, 2024-12-31) — Current Debt And Capital Lease Obligation: 313000000.00
CLN.SW balance_sheet (annual, 2024-12-31) — Current Liabilities: 1451000000.00
CLN.SW balance_sheet (quarterly, 2024-12-31) — Current Liabilities: 1451000000.00
CLN.SW balance_sheet (annual, 2024-12-31) — Current Provisions: 200000000.00